Cargando…
Therapeutic Management and Long-Term Outcome of Hyperthyroidism in Patients with Antithyroid-Induced Agranulocytosis: A Retrospective, Multicenter Study
Background: Antithyroid drug-induced agranulocytosis (AIA) (neutrophils <500/µL) is a rare but serious complication in the treatment of hyperthyroidism. Methodology: Adult patients with AIA who were followed up at 12 hospitals in Spain were retrospectively studied. A total of 29 patients were stu...
Autores principales: | García Gómez, Carlos, Navarro, Elena, Alcázar, Victoria, López-Guzmán, Antonio, Arrieta, Francisco, Anda, Emma, Biagetti, Betina, Guerrero-Pérez, Fernando, Villabona, Carles, de Assín Valverde, Andrés Ruiz, Lamas, Cristina, Lecumberri, Beatriz, Rosado Sierra, José Antonio, Sastre, Julia, Díez, Juan José, Iglesias, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607319/ https://www.ncbi.nlm.nih.gov/pubmed/37892693 http://dx.doi.org/10.3390/jcm12206556 |
Ejemplares similares
-
Therapeutic Plasma Exchange for the Treatment of Hyperthyroidism: Approach to the Patient with Thyrotoxicosis or Antithyroid-Drugs Induced Agranulocytosis
por: Tizianel, Irene, et al.
Publicado: (2023) -
Antithyroid Drug-Induced Agranulocytosis: A Case Report
por: MacKay, Micaela, et al.
Publicado: (2023) -
Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management
por: Vicente, Nuno, et al.
Publicado: (2017) -
Use of unconventional antithyroid therapy in patients with thiamazole agranulocytosis in the context of the COVID-19 pandemic
por: Alvarez-Gamero, Julio César, et al.
Publicado: (2022) -
Antithyroid drug induced agranulocytosis: what still we need to learn ?
por: Chaudhry, Liaqat Ali, et al.
Publicado: (2016)